CRP and COVID-19: In the progression phase, patients with COVID-19 present higher levels of CRP than those in a stable state, and its measurement at 7 days of hospitalization has been found to be a reliable marker to evaluate the response to treatment in patients with moderate or severe COVID-19 [58].